Tesamorelin × NG Peptide — lab test, May 2026
ILS Laboratories publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone. Every COA we issue includes a unique QR code. Anyone — your customers, regulators, or distribution partners — can scan it to instantly verify the authenticity of the results.
This certificate carries no lookup code.
Test results
Not on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 20 mg · Lab measured 20.71 mg
104% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 5.2 mg using the measured mass, against 5 mg on the label — 4% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of Tesamorelin from NG Peptide, performed by ILS Laboratories on May 10, 2026. Reported purity: 99.48%. Net content: 20.71 mg against 20 mg labeled (104% of label). Batch TSM20-3. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of Tesamorelin from NG Peptide
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| TIC338-01 | 12 May 2026 | ILS Laboratories | 99.92% | 103% | Unverified |
| TSM11 | 18 Apr 2026 | ILS Laboratories | 99.4% | 104% | Unverified |
| TS/PA-1736 | 16 Apr 2026 | ILS Laboratories | 99.98% | 105% | Unverified |
| TSM089-26 | 18 Feb 2026 | Freedom Diagnostics | 99.49% | 132% | Unverified |
| TSM09-26 | 5 Feb 2026 | Janoshik Labs | 99.779% | 117% | Unverified |
| TS07 | 3 Oct 2025 | BioRegen | 99.7% | 103% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion